For media inquiries, please contact media@yazbeckinvestments.com.

CDx CEO Featured Panelist at Marijuana Investor, Technology and Healthcare Events

MyDx, Inc. was featured at several events including the Marijuana Investor Summit and Med MJ conferences in Denver, Colorado, where we participated in panels covering Technology and Software in the MMJ Space. We are also grateful for the opportunity to contribute to the “Shark Tank” Panel sessions at the Arcview Investor Forum in Washington, DC., the same forum where CDx kicked off its Series A financing activities back in January of 2014.

NASDAQ Globenewswire

MyDx Announces Up-listing to OTCQB Marketplace

Per our plans, MyDx, Inc. has successfully up-listed to the NASDAQ OTCQB marketplace, further marking our commitment to the high level of financial and corporate disclosure that is required to participate on this exchange.

MyDx Signs Exclusive Patent Sublicense Agreement for Chemical Sensing Technology

MyDx, Inc. has further secured its competitive position and first mover advantage in the handheld chemical analysis space by executing an exclusive sublicense agreement with Next Dimension Technologies for its electronic nose chemical sensing technology used by NASA and funded by the Bill & Melinda Gates Foundation.

Yahoo Finance MyDx

MyDx, Inc. Announces Completion of Reverse Merger

SAN DIEGO, CA–(Marketwired – May 05, 2015) – MyDx, Inc., Nevada corporation (MYDX) (the “Company”), has completed a reverse merger on May 5, 2015 pursuant to which CDx, Inc., a Delaware corporation, became a wholly owned subsidiary of the Company.